Quote:
Originally Posted by Replaced_Texan
|
Useful. I know of a couple not on there, like I was looking today at a clinical trial using Fingolimod, an MS drug that is an immunosuppresent, to assist COVID-19 patients on ventilators. But my bet is that there are biotech companies and academic labs all over the country looking at what they have and whether there is some way or aspect it can deal with CVD 19, especially given that it presents so many different ways. All that pre-phase 1 stuff and repurposing of existing therapies we'll never fully capture.
